Skip to main content

Table 2 Demographic data, tumor location, patients’ comorbidities – EC (Elettrocautery); HS (Harmonic Scalpel); SM (LigaSure); TB (ThunderBeat); UEQ (Upper-External Quarter); UIQ (Upper-Internal Quarter); LEQ (Lower-External Quarter); LIQ (Lower-Internal Quarter)

From: Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation

  EC HS LS TB
Patients, n. 25 25 25 25
Age – median [range], yrs 52 [33–70] 49 [35–73] 45 [27–61] 54 [37–68]
Laterality – right breast, n. (%) 15 (61%) 18 (72%) 11 (44%) 14 (56%)
Tumor location – UEQ, n. (%) 13 (52%) 14 (56%) 15 (60%) 11 (44%)
Tumor location – UIQ, n. (%) 6 (24%) 5 (20%) 6 (24%) 7 (28%)
Tumor location – LEQ, n. (%) 4 (16%) 4 (16%) 4 (16%) 3 (12%)
Tumor location – LIQ, n. (%) 2 (8%) 2 (8%) 0 (0%) 4 (16%)
Body mass index - median [range], Kg/m2 27,1 [19–35] 26 [20,5–34] 24,5 [18,6-30,2] 26,8 [22–31,5]
Comorbidities – hypertension, n. (%) 5 (20%) 6 (24%) 4 (16%) 5 (20%)
Comorbidities – Diabetes, n. (%) 1 (4%) 1 (4%) 1 (4%) 0 (0%)